CoreCap Advisors LLC Has $241,000 Stock Position in CVS Health Co. (NYSE:CVS)

CoreCap Advisors LLC boosted its stake in CVS Health Co. (NYSE:CVS) by 6.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,057 shares of the pharmacy operator’s stock after buying an additional 186 shares during the period. CoreCap Advisors LLC’s holdings in CVS Health were worth $241,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Legato Capital Management LLC grew its position in shares of CVS Health by 12.8% during the 4th quarter. Legato Capital Management LLC now owns 67,505 shares of the pharmacy operator’s stock worth $5,330,000 after purchasing an additional 7,635 shares in the last quarter. Premier Path Wealth Partners LLC bought a new position in CVS Health in the 4th quarter valued at approximately $1,565,000. Klein Pavlis & Peasley Financial Inc. bought a new position in CVS Health in the 4th quarter valued at approximately $1,515,000. Dixon Fnancial Services Inc. lifted its stake in CVS Health by 2.4% in the 4th quarter. Dixon Fnancial Services Inc. now owns 6,195 shares of the pharmacy operator’s stock valued at $489,000 after purchasing an additional 144 shares during the last quarter. Finally, Lantz Financial LLC bought a new position in CVS Health in the 4th quarter valued at approximately $230,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS stock opened at $79.43 on Thursday. The firm has a market cap of $99.96 billion, a price-to-earnings ratio of 12.30, a P/E/G ratio of 1.04 and a beta of 0.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. CVS Health Co. has a 52 week low of $64.41 and a 52 week high of $83.25. The firm’s 50-day simple moving average is $75.61 and its two-hundred day simple moving average is $73.42.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. During the same quarter in the previous year, the firm posted $1.99 earnings per share. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. As a group, equities analysts forecast that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 3.35%. CVS Health’s dividend payout ratio is currently 41.18%.

Insider Activity at CVS Health

In related news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.25% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CVS. StockNews.com downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Royal Bank of Canada dropped their price target on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Piper Sandler increased their price objective on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Finally, TD Cowen decreased their price objective on shares of CVS Health from $102.00 to $99.00 and set an “outperform” rating for the company in a research report on Monday, December 11th. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.21.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.